Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 41 | 40 | −1 |
| Shares | 23.3M | 25.1M | +1.77M (+7.6%) |
| Value | $32.4M | $32.1M | −$320.5K (−1.0%) |
New holders (4)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acuitas Investments, LLC | 460,385 | $589.3K | 0.34% |
| Squarepoint Ops LLC | 64,013 | $81.9K | 0.00% |
| XTX Topco Ltd | 13,309 | $17.0K | 0.00% |
| Stifel Financial Corp | 12,264 | $15.7K | 0.00% |
Sold out (5)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Velan Capital Investment Management LP | 140,000 | $194.6K |
| Bailard, Inc. | 28,500 | $39.6K |
| Man Group plc | – | $35.3K |
| Charles Schwab Investment Management Inc | 24,712 | $34.4K |
| Susquehanna International Group, LLP | 20,120 | $28.0K |